Neosaxitoxin API Manufacturers

compare suppliers & get competitive offers

Pharmaoffer_donkere_achtergrond
No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for Neosaxitoxin is listed?

Join our notification list by following this page.

List your company
Are you a supplier of Neosaxitoxin or other APIs and are you looking to list your company on Pharmaoffer?

Click the button below to find out more

Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?

Click the button below to switch over to the contract services area of Pharmaoffer.

Looking for Neosaxitoxin API 64296-20-4?

Description:
Here you will find a list of producers, manufacturers and distributors of Neosaxitoxin. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Neosaxitoxin 
Synonyms:
 
Cas Number:
64296-20-4 
DrugBank number:
DB12989 
Unique Ingredient Identifier:
6YRL8BWD9H

General Description:

Neosaxitoxin, identified by CAS number 64296-20-4, is a notable compound with significant therapeutic applications. Neosaxitoxin is under investigation in clinical trial NCT01786655 (Safety Study of Long-Acting Local Anesthetic).

Classification:

Neosaxitoxin belongs to the class of organic compounds known as saxitoxins, gonyautoxins, and derivatives. These are compounds with a structure based on a 2,6-diamino-4-methyl-pyrrolo[1,2-c]purin-10-ol skeleton, classified under the direct parent group Saxitoxins, gonyautoxins, and derivatives. This compound is a part of the Organic compounds, falling under the Phenylpropanoids and polyketides superclass, and categorized within the Saxitoxins, gonyautoxins, and derivatives class, specifically within the None subclass.

Categories:

Neosaxitoxin is categorized under the following therapeutic classes: Agrochemicals, Bacterial Toxins, Biological Factors, Central Nervous System Depressants, Complex Mixtures, Compounds used in a research, industrial, or household setting, Cyanobacteria Toxins, Heterocyclic Compounds, Fused-Ring, Insecticides, Marine Toxins, Mollusk Venoms, Neuromuscular Agents, Neuromuscular Blocking Agents, Peripheral Nervous System Agents, Pesticides, Purines, Toxic Actions, Toxins, Biological, Venoms. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.

Neosaxitoxin is a type of Anesthetics


Anesthetics are a crucial category of pharmaceutical Active Pharmaceutical Ingredients (APIs) widely used in the field of medicine. These substances play a vital role in inducing a temporary loss of sensation or consciousness, enabling medical procedures to be performed without pain or discomfort. Anesthetics can be classified into two primary types: general anesthetics and local anesthetics.

General anesthetics act on the central nervous system, producing a reversible loss of consciousness. They are administered through inhalation or injection routes and are commonly employed for major surgeries or procedures that require deep sedation. Examples of general anesthetics include sevoflurane, propofol, and isoflurane.

On the other hand, local anesthetics primarily target a specific region or part of the body, temporarily numbing the area and blocking pain signals. These APIs are frequently used in dental procedures, minor surgeries, and childbirth. Common local anesthetics include lidocaine, bupivacaine, and ropivacaine.

Anesthetics work by interfering with the transmission of nerve signals or by altering the activity of certain receptors in the nervous system. They offer precise control over pain management, allowing medical professionals to perform complex procedures with reduced patient discomfort and anxiety.

The development and manufacturing of anesthetics APIs require stringent quality control measures to ensure safety and efficacy. Pharmaceutical companies adhere to strict regulatory guidelines to produce high-quality APIs. The demand for anesthetics remains consistently high, making this category of APIs a critical component of the pharmaceutical industry.

In conclusion, anesthetics are indispensable pharmaceutical APIs used to induce temporary loss of sensation or consciousness. They can be classified into general and local anesthetics, each serving distinct purposes in medical procedures. The proper development and manufacturing of anesthetics APIs are essential to ensure safe and effective pain management in various healthcare settings.